Article

Young Women Diagnosed With Cancer Experience Poor Employment, Financial Outcomes

Women diagnosed with cancer as adolescents or young adults can be especially vulnerable to the impact of the disease and its treatment on their ability to work.

Women diagnosed with cancer as adolescents or young adults can be especially vulnerable to the impact of the disease and its treatment on their ability to work, according to a study published in the American Cancer Society. These employment disruptions have the potential to become financial hardships that significantly impact the lives of these female patients.

In the study, conducted at the University of North Carolina at Chapel Hill, the researchers surveyed 1328 women in North Carolina and California who were diagnosed with cancer between the ages of 15 and 39 years and who were also employed at the time of their diagnosis.

The researchers surveyed these women at a median of 7 years following diagnosis. The survey questions were designed to assess the impact of a cancer diagnosis and treatment on various aspects of survivorship.

Upon assessing the results, the researchers found that 32% of the women surveyed experienced employment disruption, which meant that they either stopped working altogether or worked fewer hours following their diagnosis.

Twenty-seven percent of the women surveyed reported that they needed to borrow money, go into debt, or file for bankruptcy due to their cancer treatment. Additionally, there was a 17% higher likelihood of women with disrupted employment needing to borrow money, go into debt, or file for bankruptcy than women without disrupted employment.

Furthermore, 50% of the women surveyed reported experiencing psychological distress due to large medical bills related to their cancer treatment. Those women who experienced disrupted employment also had an 8% higher likelihood of reporting this than women without disrupted employment.

"Our study addresses the burden of employment disruption and financial hardship among young women with cancer—a group who may be at particular risk for poor financial outcomes after cancer given their age and gender," said co-author of the study Clare Meernik, MPH, a social/clinical research specialist at the University of North Carolina at Chapel Hill, in a press release. "Our findings highlight the need for effective interventions to promote job maintenance and transition back to the workforce after cancer treatment, as well as increased workplace accommodations and benefits, to improve cancer outcomes for young women."

REFERENCE

Study examines cancer's effects on young women's employment and finances. Wiley; October 12, 2020. eurekalert.org/pub_releases/2020-10/w-sec100720.php. Accessed October 14, 2020.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards